West Pharmaceutical Services Long Term Debt 2010-2024 | WST

West Pharmaceutical Services long term debt for the quarter ending September 30, 2024 was $0.203B, a 33.2% increase year-over-year.

  • West Pharmaceutical Services long term debt for 2023 was $0.073B, a 64.78% decline from 2022.
  • West Pharmaceutical Services long term debt for 2022 was $0.207B, a 1.01% decline from 2021.
  • West Pharmaceutical Services long term debt for 2021 was $0.209B, a 17.44% decline from 2020.

West Pharmaceutical Services Long Term Debt 2010-2024 | WST

  • West Pharmaceutical Services long term debt for 2023 was $0.073B, a 64.78% decline from 2022.
  • West Pharmaceutical Services long term debt for 2022 was $0.207B, a 1.01% decline from 2021.
  • West Pharmaceutical Services long term debt for 2021 was $0.209B, a 17.44% decline from 2020.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$78.8B
Becton Dickinson (BDX)$65.6B
Cardinal Health (CAH)$28.6B
Cooper (COO)$20.6B
Labcorp (LH)$20B
Align Technology (ALGN)$16.6B
Henry Schein (HSIC)$8.7B
Merit Medical Systems (MMSI)$5.9B
DENTSPLY SIRONA (XRAY)$3.5B
CONMED (CNMD)$2.3B
Patterson (PDCO)$1.9B
STAAR Surgical (STAA)$1.6B
Lifevantage (LFVN)$172M
Pro-Dex (PDEX)$134M